A qualitative study to evaluate physician attitudes regarding omission of surgery among exceptional responders to neoadjuvant systemic therapy for breast cancer (NRG-CC006).
Laila A GharzaiLauren A SzczygielDean A ShumwayHanna BandosThomas B JulianEleftherios P MamounasJulia WhiteJennifer F De Los SantosMark BasikPatricia A GanzReshma JagsiPublished in: Breast cancer research and treatment (2021)
Physicians expressed interest in investigating a novel approach to breast cancer treatment that would omit surgery in complete responders to neoadjuvant chemotherapy. Multidisciplinary input, and specifically surgeon engagement, will be key to the success of future investigations. Ongoing work to develop approaches to predict pathologic complete response accurately is needed to achieve the promise of this idea. ClinTrials #: BR005: NCT03188393 June 13, 2017.
Keyphrases
- machine learning
- neoadjuvant chemotherapy
- locally advanced
- lymph node
- minimally invasive
- coronary artery bypass
- rectal cancer
- primary care
- sentinel lymph node
- squamous cell carcinoma
- radiation therapy
- emergency department
- surgical site infection
- mental health
- social media
- early stage
- coronary artery disease
- atrial fibrillation
- drug induced